Fig. 1 · Structure
Documents & Downloads
CDK7-IN-13
CDK7 Inhibitor
CDK7-IN-13 is a potent inhibitor of cyclin-dependent kinase 7 (CDK7), with a pyrimidinyl derivative structure. This compound exhibits significant activity against cancer cells characterized by transcriptional dysregulation, making it a valuable tool for cancer research. Its application in studies targeting CDK7 may enhance the understanding of cancer biology and aid in the development of novel therapeutic strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2765676-20-6 |
| Applications | CDK7 Inhibitor |
| Formula | C20H23F3N6OS |
| Molecular Weight | 452.50 |
| SMILES | CS(C)(=O)=NC1=CC=CC2=C1NC=C2C3=NC(N[C@H]4CCCNC4)=NC=C3C(F)(F)F |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.